A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above
Clinical trial NCT01607112 · COMPLETED
Trial details
- NCT number
- NCT01607112
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-10
- Primary completion
- 2012-07-31
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.